US health officials today approved the first Alzheimer’s drug proven to slow the condition – in what could be a breakthrough for millions of patients. Lecanemab, which will be sold under the brand name Leqembi, instantly becomes the most effective treatment on the market after being given accelerated approval by the Food and Drug Administration (FDA)…
A breakthrough treatment that slows Alzheimer’s disease has boosted scientists’ hopes for two more experimental drugs. Lecanemab, which is given as an injection every two weeks, was found to slow the progress of Alzheimer’s disease in patients by 27 per cent. It makes it the first ever drug shown to arrest the progression of the…
An experimental Alzheimer’s drug developed by Eisai Co Ltd and Biogen Inc significantly slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, the companies said on Tuesday. The injected drug, lecanemab, slowed progress of the brain-wasting disease by 27 percent compared to a placebo, meeting the…
Tony Bennett was out and about in Manhattan on Thursday, smiling beside his wife Susan as he was pushed through Central Park in a wheelchair. The 95-year-old Queens-born entertainer has lived most of his live in New York City, and calls home an expansive penthouse overlooking Central Park. He moved to his apartment on Central Park…